The Effectiveness of Neuropad® for Assessing Diabetic Neuropathy

Accurately assessing diabetic autonomic neuropathy is one of the most important things that can be done to prevent diabetes-related lower extremity amputations. The American Diabetes Association Standards of Cares says all individuals with type 1 diabetes for five years or longer and those with type 2 diabetes should be assessed annually for autonomic neuropathy. There are simple, effective tools to complete these assessments, and Neuropad® is one of them.